Rokid and Eyedaptic Launch EYE5 to Help AMD Patients Enhance Their Vision
HANGZHOU, China, Nov. 24, 2022 /PRNewswire/ -- Recently, Rokid, an augmented reality glasses manufacturer, partnered with Eyedaptic to unveil the all-new EYE5 smart glasses at the American Academy of Optometry 2022 Annual Meeting and Expo. The latest model brings wearability to a whole new level and covers the widest range of use cases for central vision loss including Diabetic Retinopathy...
Vieworks exhibits at RSNA 2022 with its complete lineup of next generation x-ray flat panel detectors
ANYANG, South Korea, Nov. 24, 2022 /PRNewswire/ -- Vieworks, a leading digital x-ray imaging solution provider based in South Korea, will be exhibiting its complete lineup of DR flat panel detectors (FPD) and dynamic FPDs at RSNA 2022 (South Hall #1723) from November 27th to November 30th. Celebrating the FDA-approval of VIVIX-S F series, the...
Edenlux launches AI-based service “Otus Plus Eye Health Care Report”
SEOUL, South Korea, Nov. 24, 2022 /PRNewswire/ -- On November 24, Edenlux (CEO Sy Park) announced that it will provide an artificial intelligence (AI) eye health management report for the users of Otus Plus, its flagship product. Edenlux Otus Plus APP The company, which is a member of the Born2Global Centre (CEO Kim Jong-gap), created the Otus...
IonOpticks ushers in a new age of proteomics with Aurora Frontier
MELBOURNE, Australia, Nov. 24, 2022 /PRNewswire/ -- The field of proteomics is set to be revolutionised with the launch today of IonOpticks' Aurora Frontier that achieves more than 10,000 proteins per sample. This near-full proteome coverage, a depth previously considered unattainable, unlocks the potential for ground-breaking scientific discoveries in human health. Proteomics provides a greater understanding of the complexity of...
The 13th China (Taizhou) International Medical Expo successfully held
TAIZHOU, China, Nov. 24, 2022 /PRNewswire/ -- From November 19 to 21, the 13th China (Taizhou) International Medical Expo was held in China Medical City (CMS). Themed "Healthy China Strategy Leading the Construction of Demonstration Zones", this year's expo held 23 special events including the CMS Policy Releasing and Project Signing Ceremony, and the 9th China (Taizhou) International Big...
AcuCort signs its first commercial agreement for the company’s drug Zeqmelit™
LUND, Sweden, Nov. 24, 2022 /PRNewswire/ -- AcuCort AB (publ) (Spotlight Stock Market: ACUC) today announces that the company has signed an exclusive commercial agreement with the global biopharmaceutical company Kamada Ltd., (NASDAQ: KMDA; TASE: KMDA.TA). The agreement gives Kamada the exclusive right to the marketing and sales as well as the distribution of AcuCort's drug Zeqmelit™ for, among other...
Korea Ginseng Corp.: As an adaptogenic herb, Korean red ginseng boosts the human immune response
KORESELECT Immune receives the 2022 Taste For Life Immunity Essential award CERRITOS, Calif., Nov. 23, 2022 /PRNewswire/ -- Korean Ginseng Corp., the world's number one Korean red ginseng brand, is highlighting Korean red ginseng as another way to stay healthy. Korea Ginseng Corp.: As an adaptogenic herb, Korean red ginseng boosts the human...
AnchorDx Enrolls the First Patient For Its UriFind® Bladder Cancer Assay Clinical Trial in the U.S.
GUANGZHOU, China, Nov. 23, 2022 /PRNewswire/ -- AnchorDx, a world-leading developer of cancer early detection solutions, announced the first patient enrollment for the UriFind® bladder cancer assay clinical trial in the U.S., an over 1,000-patient multi-center, prospective testing of the assay in the targeted patients. This prospective, registrational study is aimed to...
Kinseed Selects Solace’s Event Streaming and Management Solution to Accelerate Digital Transformation in the Healthcare Industry
Leading healthcare IT provider revolutionizing the patient data journey with event-driven architecture LONDON, Nov. 23, 2022 /PRNewswire/ -- Solace, the leading enabler of event-driven architecture (EDA) for real-time enterprises, announced today that UK-based Kinseed is using Solace's event streaming and management solution, PubSub+ Platform, to improve and expand the real-time data distribution...
Ascletis Announces IND Approval of Oral 3CLpro Inhibitor ASC11 for COVID-19 by U.S. FDA
--The Phase I clinical trial will consist of 3 cohorts in healthy subjects, including single- and multiple-dose escalation studies and food effect study. The objective of Phase I trial is to find a right dose to move into the pivotal Phase II/III in COVID-19 patients --In antiviral cellular assays with infectious SARS-CoV-2, ASC11 demonstrated much higher potency...
